239 related articles for article (PubMed ID: 29579075)
1. Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury.
Phillips EG; Beggs LA; Ye F; Conover CF; Beck DT; Otzel DM; Ghosh P; Bassit ACF; Borst SE; Yarrow JF
PLoS One; 2018; 13(3):e0194440. PubMed ID: 29579075
[TBL] [Abstract][Full Text] [Related]
2. Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss.
Beggs LA; Ye F; Ghosh P; Beck DT; Conover CF; Balaez A; Miller JR; Phillips EG; Zheng N; Williams AA; Aguirre JI; Wronski TJ; Bose PK; Borst SE; Yarrow JF
J Bone Miner Res; 2015 Apr; 30(4):681-9. PubMed ID: 25359699
[TBL] [Abstract][Full Text] [Related]
3. Locomotor training with adjuvant testosterone preserves cancellous bone and promotes muscle plasticity in male rats after severe spinal cord injury.
Yarrow JF; Kok HJ; Phillips EG; Conover CF; Lee J; Bassett TE; Buckley KH; Reynolds MC; Wnek RD; Otzel DM; Chen C; Jiron JM; Graham ZA; Cardozo C; Vandenborne K; Bose PK; Aguirre JI; Borst SE; Ye F
J Neurosci Res; 2020 May; 98(5):843-868. PubMed ID: 31797423
[TBL] [Abstract][Full Text] [Related]
4. Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injury.
Yarrow JF; Conover CF; Beggs LA; Beck DT; Otzel DM; Balaez A; Combs SM; Miller JR; Ye F; Aguirre JI; Neuville KG; Williams AA; Conrad BP; Gregory CM; Wronski TJ; Bose PK; Borst SE
J Neurotrauma; 2014 May; 31(9):834-45. PubMed ID: 24378197
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats After Chronic Spinal Cord Injury.
Zhao W; Li X; Peng Y; Qin Y; Pan J; Li J; Xu A; Ominsky MS; Cardozo C; Feng JQ; Ke HZ; Bauman WA; Qin W
Calcif Tissue Int; 2018 Oct; 103(4):443-454. PubMed ID: 29931461
[TBL] [Abstract][Full Text] [Related]
6. Testosterone Plus Finasteride Prevents Bone Loss without Prostate Growth in a Rodent Spinal Cord Injury Model.
Yarrow JF; Phillips EG; Conover CF; Bassett TE; Chen C; Teurlings T; Vasconez A; Alerte J; Prock H; Jiron JM; Flores M; Aguirre JI; Borst SE; Ye F
J Neurotrauma; 2017 Nov; 34(21):2972-2981. PubMed ID: 28338402
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats.
Qin W; Li X; Peng Y; Harlow LM; Ren Y; Wu Y; Li J; Qin Y; Sun J; Zheng S; Brown T; Feng JQ; Ke HZ; Bauman WA; Cardozo CC
J Bone Miner Res; 2015 Nov; 30(11):1994-2004. PubMed ID: 25974843
[TBL] [Abstract][Full Text] [Related]
8. A 50 kdyne contusion spinal cord injury with or without the drug SS-31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice.
Graham ZA; DeBerry JJ; Cardozo CP; Bamman MM
Physiol Rep; 2021 Feb; 9(4):e14751. PubMed ID: 33611851
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury.
Byers JS; Huguenard AL; Kuruppu D; Liu NK; Xu XM; Sengelaub DR
J Comp Neurol; 2012 Aug; 520(12):2683-96. PubMed ID: 22314886
[TBL] [Abstract][Full Text] [Related]
10. Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization.
Ye F; Baligand C; Keener JE; Vohra R; Lim W; Ruhella A; Bose P; Daniels M; Walter GA; Thompson F; Vandenborne K
J Neurotrauma; 2013 Feb; 30(3):227-35. PubMed ID: 22985272
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin-Neutralizing Antibody Enhances Bone Regeneration Around Oral Implants.
Yu SH; Hao J; Fretwurst T; Liu M; Kostenuik P; Giannobile WV; Jin Q
Tissue Eng Part A; 2018 Nov; 24(21-22):1672-1679. PubMed ID: 29921173
[TBL] [Abstract][Full Text] [Related]
13. Contusion spinal cord injury upregulates p53 protein expression in rat soleus muscle at multiple timepoints but not key senescence cytokines.
Graham ZA; Goldberger A; Azulai D; Conover CF; Ye F; Bauman WA; Cardozo CP; Yarrow JF
Physiol Rep; 2020 Feb; 8(3):e14357. PubMed ID: 32026570
[TBL] [Abstract][Full Text] [Related]
14. Cycling exercise and fetal spinal cord transplantation act synergistically on atrophied muscle following chronic spinal cord injury in rats.
Peterson CA; Murphy RJ; Dupont-Versteegden EE; Houlé JD
Neurorehabil Neural Repair; 2000; 14(2):85-91. PubMed ID: 15470819
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury.
Roudier M; Li X; Niu QT; Pacheco E; Pretorius JK; Graham K; Yoon BR; Gong J; Warmington K; Ke HZ; Black RA; Hulme J; Babij P
Arthritis Rheum; 2013 Mar; 65(3):721-31. PubMed ID: 23233270
[TBL] [Abstract][Full Text] [Related]
16. Exercise-induced gene expression in soleus muscle is dependent on time after spinal cord injury in rats.
Dupont-Versteegden EE; Houlé JD; Dennis RA; Zhang J; Knox M; Wagoner G; Peterson CA
Muscle Nerve; 2004 Jan; 29(1):73-81. PubMed ID: 14694501
[TBL] [Abstract][Full Text] [Related]
17. Osteocytes reflect a pro-inflammatory state following spinal cord injury in a rodent model.
Metzger CE; Gong S; Aceves M; Bloomfield SA; Hook MA
Bone; 2019 Mar; 120():465-475. PubMed ID: 30550849
[TBL] [Abstract][Full Text] [Related]
18. A Soluble Activin Receptor IIB Fails to Prevent Muscle Atrophy in a Mouse Model of Spinal Cord Injury.
Graham ZA; Collier L; Peng Y; Saéz JC; Bauman WA; Qin W; Cardozo CP
J Neurotrauma; 2016 Jun; 33(12):1128-35. PubMed ID: 26529111
[TBL] [Abstract][Full Text] [Related]
19. Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats.
Liu M; Stevens-Lapsley JE; Jayaraman A; Ye F; Conover C; Walter GA; Bose P; Thompson FJ; Borst SE; Vandenborne K
Eur J Appl Physiol; 2010 Jul; 109(4):709-20. PubMed ID: 20213470
[TBL] [Abstract][Full Text] [Related]
20. Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation.
Beehler BC; Sleph PG; Benmassaoud L; Grover GJ
Exp Biol Med (Maywood); 2006 Mar; 231(3):335-41. PubMed ID: 16514182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
